2-Hydroxy-2-(4-propoxyphenyl)acetic acid, 95.0%, 500g

N-((Tetrahydro-2H-pyran-2-yl)oxy)acrylamide, 98%, 1g

1-Acetyl-5-bromoindoline>98.0%(GC)25g

1-Benzylazepan-4-amine, 98%, 250mg

2-Bromo-5-thiazolecarboxylic acid, 97.0%, 100g

4-(tert-Butyl)-N-(4-(tert-butyl)phenyl)-N-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)aniline, 98%, 5g

(1R,2R)-2-Fluorocyclopropan-1-amine hydrochloride, 98+%, 5g

N-(2-((5-Chloro-2-((2-methoxy-4-morpholinophenyl)amino)pyrimidin-4-yl)amino)phenyl)methanesulfonamide, 98%, 5mg

EWF 10x/20 mm eyepiece with pointing needle, Ø 23.2 mm tube

4-(Trifluoromethyl)pyrimidine-2-carbaldehyde, 98%, 1g

N-[(1S,2S)-2-(Dimethylamino)cyclohexyl]-N'-[(1S,2R)-2-hydroxy-1,2-diphenylethyl]thiourea, 97%, 100mg

3-Amino-4-chlorobenzoic acid, 98.0%, 25g

6-methoxy-2-(5-methyl-2-furanyl)-N-(1-methyl-4-piperidinyl)-7-[3-(1-pyrrolidinyl)propoxy]-4-quinolinamine, 100mg